November 2023
-
11.21.2023 Financial Finance Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference -
11.02.2023 Research and Pipeline Research Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting -
11.02.2023 Financial Finance Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
October 2023
-
10.31.2023 Pfizer Reports Third-Quarter 2023 Results -
10.26.2023 Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 -
10.20.2023 Prescription Medicines Vaccines FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents -
10.13.2023 Corporate Finance Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance -
10.13.2023 Prescription Medicines Medicines U.S. FDA Approves Pfizer’s VELSIPITY™ for Adults with Moderately to Severely Active Ulcerative Colitis (UC) -
10.12.2023 Prescription Medicines Medicines U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer -
10.05.2023 Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases -
10.04.2023 Financial Finance Pfizer Declares Fourth-Quarter 2023 Dividend
September 2023
-
09.22.2023 Vaccines Vaccines Pfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO™ for RSV